1508901

Pentoxifylline

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): 3,7-Dimethyl-1-(5-oxohexyl)xanthine, Trental
• Empirical Formula (Hill Notation): C₁₃H₁₈N₄O₃
• CAS Number: 6493-05-6
• Molecular Weight: 278.31
• MDL number: MFCD00063379
• UNSPSC Code: 41116107
• PubChem Substance ID: 329750705
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: pentoxifylline
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: CN1C=NC2C1C(=O)N(CCCCC(C)=O)C(=O)N2C
• InChI: 1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8,10-11H,4-7H2,1-3H3
• InChI key: MQGNNJQTNFHNHK-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Pentoxifylline USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Pentoxifylline Compounded Oral Suspension
• Pentoxifylline Extended-Release Tablets

Biochem/physiol Actions

Phosphodiesterase inhibitor; inhibits synthesis of tumor necrosis factor α (TNF-α).

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Statements: H302,H362
• Precautionary Statements: P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Lact.
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3